GM-CSF

Orphan Drug Cold Chain RequiredFDA Approved

Description

Sargramostim is a recombinant human granulocyte-macrophage colony-stimulating factor (rhuGM-CSF) that stimulates the proliferation, differentiation, and functional activity of granulocytes and macrophages. It is used to treat autoimmune pulmonary alveolar proteinosis.

Indications & Therapeutic Use

Autoimmune Pulmonary Alveolar Proteinosis

Linked Diseases:

Global Availability (1 countries)

CountryAccess RouteRegulatory PathwayLead TimeStatus

Available Through

This drug is available for procurement through the following fulfilment partner.

Fulfilment Partner
GM-CSF
Generic NameGM-CSF
Brands1 brand available
Active IngredientSargramostim
Drug ClassAutoimmune Pulmonary Alveolar Proteinosis
ManufacturerPartner Therapeutics
Dosage FormsPowder for solution
Medical CodeL03AA02
Orphan StatusYes — Orphan Drug
Cold ChainRequired
Reg. StatusFDA Approved
Clinical TrialNCT00002949
Countries1 countries
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations2 Validated Nodes